- Home
- Healthcare professionals
- ACE Technology Guidances
- Drug Guidance
- Long-acting erythropoiesis-stimulating agents for treating anaemia in chronic kidney disease
Withdrawn
Long-acting erythropoiesis-stimulating agents for treating anaemia in chronic kidney disease
1 September 2023
Published on 04 Jan 2022
Last Updated on 01 Sep 2023
Long-acting erythropoiesis-stimulating agents for treating anaemia in chronic kidney disease Guidance is outdated and has been withdrawn on 1 Sep 2023. The Plain English Summary (PES) has been updated on 1 Sep 2023.